94790-24-6 Usage
Description
oc-O-Methyl-L-TyrosineMethylEster is a chemical compound derived from the amino acid tyrosine, specifically as an ester derivative of 3-O-methyl-L-tyrosine. It is primarily utilized in the fields of organic chemistry and biochemistry for research purposes. oc-O-Methyl-L-TyrosineMethylEster has demonstrated potential pharmacological properties, making it a promising candidate for drug development. Furthermore, it has been investigated for its possible therapeutic role in the treatment of specific neurological and psychiatric disorders. However, additional research is necessary to fully comprehend its biological activities and potential applications in medicine.
Uses
Used in Organic Chemistry Research:
oc-O-Methyl-L-TyrosineMethylEster is used as a research compound in organic chemistry for studying its chemical properties and potential reactions with other molecules.
Used in Biochemical Research:
In biochemistry, oc-O-Methyl-L-TyrosineMethylEster serves as a research tool to explore its interactions with biological systems and understand its role in various biochemical processes.
Used in Drug Development:
oc-O-Methyl-L-TyrosineMethylEster is used as a potential candidate in drug development due to its demonstrated pharmacological properties, which may lead to the creation of new therapeutic agents.
Used in Pharmaceutical Industry:
Within the pharmaceutical industry, oc-O-Methyl-L-TyrosineMethylEster is utilized for the development and testing of new drugs, particularly those targeting neurological and psychiatric disorders.
Used in Treatment of Neurological and Psychiatric Disorders:
oc-O-Methyl-L-TyrosineMethylEster is studied for its potential role in the treatment of certain neurological and psychiatric disorders, with the aim of providing new therapeutic options for patients.
Check Digit Verification of cas no
The CAS Registry Mumber 94790-24-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,4,7,9 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 94790-24:
(7*9)+(6*4)+(5*7)+(4*9)+(3*0)+(2*2)+(1*4)=166
166 % 10 = 6
So 94790-24-6 is a valid CAS Registry Number.
94790-24-6Relevant articles and documents
Synthesis of Enantiopure Unnatural Amino Acids by Metallaphotoredox Catalysis
Agejas, Javier,Barberis, Mario,De Frutos, Oscar,Faraggi, Tomer M.,García-Cerrada, Susana,MacMillan, David W. C.,Mateos, Carlos,Rincón, Juan A.,Rouget-Virbel, Caroline
, p. 1966 - 1973 (2021/08/18)
We describe herein a two-step process for the conversion of serine to a wide array of optically pure unnatural amino acids. This method utilizes a photocatalytic cross-electrophile coupling between a bromoalkyl intermediate and a diverse set of aryl halides to produce artificial analogues of phenylalanine, tryptophan, and histidine. The reaction is tolerant of a broad range of functionalities and can be leveraged toward the scalable synthesis of valuable pharmaceutical scaffolds via flow technology.
BORYLATED AMINO ACID COMPOSITIONS FOR USE IN BORON NEUTRON CAPTURE THERAPY AND METHODS THEREOF
-
, (2020/09/19)
Borylated Amino Acid ("BAA") compositions and methods of making BAAs are disclosed herein. Consequently, the BAAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders and other disease by utilizing a Neutron Capture Therapy modality.
Rapid Syntheses of (?)-FR901483 and (+)-TAN1251C Enabled by Complexity-Generating Photocatalytic Olefin Hydroaminoalkylation
Reich, Dominik,Trowbridge, Aaron,Gaunt, Matthew J.
supporting information, p. 2256 - 2261 (2020/01/24)
We report a common strategy to facilitate the syntheses of the polycyclic alkaloids (?)-FR901483 (1) and (+)-TAN1251C (2). A divergent synthetic strategy provides access to both natural products through a pivotal spirolactam intermediate (3), which can be accessed on a gram-scale. A photocatalytic olefin hydroaminoalkylation brings together three readily available building blocks and forges the majority of the carbon framework present in 1 and 2 in a single operation, leading to concise total syntheses. The complexity-generating photocatalytic process also provides direct access to novel non-racemic spirolactam scaffolds that are likely to be of interest to early-stage drug discovery programs.